Philippe Eggimann

ORCID: 0000-0002-2615-6615
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Nosocomial Infections in ICU
  • Antifungal resistance and susceptibility
  • Sepsis Diagnosis and Treatment
  • Healthcare Systems and Practices
  • Antibiotic Use and Resistance
  • Central Venous Catheters and Hemodialysis
  • Pneumonia and Respiratory Infections
  • Antimicrobial Resistance in Staphylococcus
  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Bacterial Identification and Susceptibility Testing
  • Fungal Infections and Studies
  • Infective Endocarditis Diagnosis and Management
  • Pancreatitis Pathology and Treatment
  • Health, Medicine and Society
  • Streptococcal Infections and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Infection Control in Healthcare
  • Burn Injury Management and Outcomes
  • Respiratory Support and Mechanisms
  • Patient Safety and Medication Errors
  • Neutropenia and Cancer Infections
  • Cardiac Arrest and Resuscitation
  • Intensive Care Unit Cognitive Disorders
  • Health and Medical Studies

University of Lausanne
2014-2024

University Hospital of Lausanne
2014-2023

Hôpital Orthopédique de la Suisse Romande
2005-2023

Herrenknecht (Germany)
2023

Engineering Associates (United States)
2017

Centre Hospitalier Universitaire de Sherbrooke
2015

MSD (Australia)
2015

Swiss Academy of Medical Sciences
2015

University Hospital of Geneva
1999-2014

UMass Memorial Health Care
2010

Candida species are among the most common bloodstream pathogens in United States, where emergence of azole-resistant glabrata and krusei major concerns. Recent comprehensive longitudinal data from Europe lacking. We conducted a nationwide survey candidemia during 1991–2000 17 university university-affiliated hospitals representing 79% all tertiary care hospital beds Switzerland. The number transplantations infections increased significantly (P < .001). A total 1137 episodes were observed:...

10.1086/380637 article EN Clinical Infectious Diseases 2004-01-19

Objective To evaluate the efficacy and safety of intravenous fluconazole for prevention intra-abdominal Candida infections in high-risk surgical patients. Design Randomized, prospective, double-blind, placebo-controlled study. Setting Two university-affiliated hospitals Switzerland. Patients Forty-nine patients with recurrent gastrointestinal perforations or anastomotic leakages. Interventions Prophylaxis (400 mg per day) placebo continued until resolution underlying condition. Measurements...

10.1097/00003246-199906000-00019 article EN Critical Care Medicine 1999-06-01

In patients with ventilator-associated pneumonia (VAP), guidelines recommend antibiotic therapy adjustment according to microbiology results after 72 h. Circulating procalcitonin levels may provide evidence that facilitates the reduction of therapy. a multicentre, randomised, controlled trial, 101 VAP were assigned an discontinuation strategy (control group) or serum concentrations (procalcitonin regimen selected by treating physician. The primary end-point was antibiotic-free days alive...

10.1183/09031936.00053209 article EN European Respiratory Journal 2009-09-24

Nosocomial pneumonia and sepsis, as well severe diffuse peritonitis, must be treated early in order to prevent complications such septic shock organ dysfunctions. With the availability of new broad-spectrum highly bactericidal antibiotics, need combining beta-lactams with aminoglycosides for treatment infections should reassessed. A prospective randomized controlled study was performed compare imipenem monotherapy a combination plus netilmicin empiric nosocomial pneumonia, peritonitis. total...

10.1128/aac.38.6.1309 article EN Antimicrobial Agents and Chemotherapy 1994-06-01

Rationale: Life-threatening intraabdominal candidiasis (IAC) occurs in 30 to 40% of high-risk surgical intensive care unit (ICU) patients. Although early IAC diagnosis is crucial, blood cultures are negative, and the role Candida score/colonization indexes not established.Objectives: The aim this prospective Fungal Infection Network Switzerland (FUNGINOS) cohort study was assess accuracy 1,3-β-d-glucan (BG) antigenemia for IAC.Methods: Four hundred thirty-four consecutive adults with...

10.1164/rccm.201211-2069oc article EN American Journal of Respiratory and Critical Care Medicine 2013-06-19

Invasive candidiasis ranges from 5 to 10 cases per 1,000 ICU admissions and represents 5% 10% of all ICU-acquired infections, with an overall mortality comparable that severe sepsis/septic shock. A large majority them are due Candida albicans, but the proportion strains decreased sensitivity or resistance fluconazole is increasingly reported. high patients become colonized, only 30% develop invasive infection. Progressive colonization major abdominal surgery common risk factors, difficult...

10.1186/2110-5820-1-37 article EN cc-by Annals of Intensive Care 2011-09-01

Hypothermia impairs blood glucose homeostasis and insulin sensitivity. However, the impact of therapeutic hypothermia on levels requirements is unknown. We analyzed variability during in patients with coma after cardiac arrest examined its outcome.Prospective observational study.Two university hospital medical/surgical intensive care units.Comatose treated (33°C, 24 hrs).Insulin therapy (blood target 6-8 mmol/L [110-150 mg/dL]), according to a written algorithm, nurse-driven adjustment...

10.1097/ccm.0b013e31822572c9 article EN Critical Care Medicine 2011-06-25
Bruno François Hasan S. Jafri Jean Chastre Miguel Sánchez García Philippe Eggimann and 95 more Pierre‐François Dequin Vincent Huberlant Lucía Viña Soria Thierry Boulain Cédric Bretonnière Jérôme Pugin Josep Trenado Ana Catalina Hernandez Padilla Omar Ali Kathryn Shoemaker Pin Ren Frank E. J. Coenjaerts Alexey Ruzin Olivier Barraud Leen Timbermont Christine Lammens Vadryn Pierre Yuling Wu Julie Vignaud Susan Colbert Terramika Bellamy Mark T. Esser Filip Dubovsky Marc J. M. Bonten Herman Goossens Pierre‐François Laterre Didier Chochrad Alain Dive Frédéric Forêt Marc A. Simon Herbert Spapen Jacques Créteur Yves Bouckaert Patrick Biston Marc Bourgeois Martin Nováček Tomáš Vymazal Petr Svoboda Jan Pachl Vladimír Šrámek Michal Hanauer Tomas Hruby Martin Balík Tomáš Suchý Alain Lepape Laurent Argaud Frédéric Dailler Arnaud Desachy Christophe Guitton Alain Mercat Ferhat Meziani Jean-Christophe Navellou R. Robert Bertrand Souweine Jean‐Marc Tadié Adel Maamar Djillali Annane Fabienne Tamion Antoine Gros Saad Nseir Carole Schwebel Gilles Francony Jean‐Yves Lefrant Francis Schneider Matthias Gründling J. Motsch Lorenz Reill Caroline Rolfes Tobias Welte Oliver A. Cornely Frank Bloos Maria Deja Katrin Schmidt Frank Wappler Andreas Meier‐Hellmann Apostolos Komnos Vasileios Bekos Vasilios Koulouras Ioanna Soultati Georgios Baltopoulos Georgios Filntisis Epaminondas Zakynthinos Spyros Zakynthinos Ioannis Pnevmatikos Ildikó Krémer Zoltán Szentkereszty Ágnes Sárkány Zsuzsa Marjanek Pedro Henrique de Moura Maria Consuelo Pintado Delgado Juan Carlos Montejo González Paula Ramírez Antonio Torres Martí Juan Carlos Valía José A. Lorente

10.1016/s1473-3099(20)30995-6 article EN publisher-specific-oa The Lancet Infectious Diseases 2021-04-21
Jean Chastre Bruno François Marc Bourgeois Apostolos Komnos Ricard Ferrer and 95 more Galia Rahav Nicolas De Schryver Alain Lepape İftihar Köksal Charles‐Édouard Luyt Miguel Sánchez García Antoní Torres Philippe Eggimann Despoina Koulenti Thomas L Holland Omar Ali Kathryn Shoemaker Pin Ren Julien Sauser Alexey Ruzin David E. Tabor Ahmad Akhgar Yuling Wu Yu Jiang Antonio DiGiandomenico Susan Colbert Drieke Vandamme Frank E. J. Coenjaerts Surbhi Malhotra‐Kumar Leen Timbermont Antonio Oliver Olivier Barraud Terramika Bellamy Marc J. M. Bonten Herman Goossens Colin Reisner Mark T. Esser Hasan S. Jafri Michael Joannidis Walter Klimscha Elisabeth De Waele Jacques Devriendt Vincent Huberlant Pieter Depuydt Sam Van Boxstael Mladen Perić Jasminka Kopić Michal Hanauer Tomas Hruby Vladimír Šrámek Petr Svoboda Tomáš Vymazal Martin Nováček Djillali Annane Jean‐Paul Mira Bertrand Souweine Pierre‐François Dequin Ferhat Meziani François Stéphan Saadalla Nseir Sébastien Gibot Carole Schwebel Gaëtan Plantefève Jean‐Luc Diehl Christian Richard Christian Lamer Kada Klouche Samir Jaber Epaminondas Zakynthinos Georgios Filntisis Spyros Zakynthinos Antonia Koutsoukou Georgios Saroglou Charikleia Nikolaou Glykeria Vlachogianni Ioannis Pnevmatikos Konstantinos Mandragos Ildikó Krémer Zsolt Dezso Rozgonyi Zsuzsa Marjanek Ignacio Martín‐Loeches Pierre Singer Vernon van Heerden Yehuda Carmeli Pedro Póvoa Antonio Alvarez Seoane Pedro Henrique de Moura Filipe Gonzalez Paula Ramírez Antonio Torres Martí Ricard Ferrer Lorena Oteiza D. Escudero Enrique Piacentini Paula Vera Luis Tamayo Miguel Angel Gonzalez Gallego B. Suberviola Cañas Iglesias Figueira Rafael Camino León

Abstract Background Ventilator-associated pneumonia caused by Pseudomonas aeruginosa (PA) in hospitalised patients is associated with high mortality. The effectiveness of the bivalent, bispecific mAb MEDI3902 (gremubamab) preventing PA nosocomial was assessed PA-colonised mechanically ventilated subjects. Methods EVADE (NCT02696902) a phase 2, randomised, parallel-group, double-blind, placebo-controlled study Europe, Turkey, Israel, and USA. Subjects ≥ 18 years old, ventilated, tracheally...

10.1186/s13054-022-04204-9 article EN cc-by Critical Care 2022-11-15

Nosocomial pneumonia is a major source of morbidity and mortality after severe burns. Burned patients suffer trace element deficiencies depressed antioxidant immune defences. This study aimed at determining the effect supplementation on nosocomial or intensive care unit (ICU)-acquired pneumonia.Two consecutive, randomised, double-blinded, studies including two homogeneous groups 41 severely burned (20 placebo 21 intervention) admitted to burn centre university hospital were combined....

10.1186/cc5084 article EN cc-by Critical Care 2006-11-02

Abstract Primary bloodstream infection (BSI) is a leading, preventable infectious complication in critically ill patients and has negative impact on patients' outcome. Surveillance definitions for primary BSI distinguish those that are microbiologically documented from not. The latter known as clinical sepsis, but information its epidemiologic importance limited. We analyzed prospective on-site surveillance data of nosocomial infections medical intensive care unit. Of the 113 episodes BSI,...

10.3201/eid1001.030407 article EN cc-by Emerging infectious diseases 2004-01-01

Iseganan, an antimicrobial peptide, is active against aerobic and anaerobic gram-positive gram-negative bacteria as well fungi yeasts. The drug has shown little resistance in vitro to be safe tolerated 800 patients with cancer treated for up 6 wk.To determine the efficacy of iseganan prevention ventilator-associated pneumonia (VAP).Mechanically ventilated United States Europe were randomized oral topical or placebo (1:1) six times per day while intubated 14 d. Patients eligible if within 24...

10.1164/rccm.200504-656oc article EN American Journal of Respiratory and Critical Care Medicine 2005-09-29
Coming Soon ...